Assoc. Prof. Dr Marie-Christine Simon | Nutritional Award | Best Scholar Award

Assoc. Prof. Dr Marie-Christine Simon |  Nutritional Award | Best Scholar Award

Assoc. Prof. Dr Marie-Christine Simon, Institute of nutrition and food research, Germany

Prof. Marie-Christine Simon is a Junior Professor of Nutrition and Microbiome at the Institute of Nutrition and Food Sciences at the University of Bonn, Germany. She leads the junior research group within the Diet Body Brain competence cluster, funded by the German Federal Ministry of Education and Research (BMBF). With several years of expertise in nutrition-related microbiome research, her work bridges key aspects of metabolism, immunology, and human health. During her doctorate at the German Diabetes Center in Düsseldorf, Prof. Simon conducted human intervention studies focusing on the effects of probiotics on insulin resistance, the incretin effect, and inflammatory markers in both overweight and lean individuals. This experience equipped her with in-depth knowledge of diabetes-related metabolic and immune changes, further complemented by her academic background in nutritional sciences.

Professional Profile:

Scopus

Orcid

Summary of Suitability for Best Scholar Award – Prof. Marie-Christine Simon

Prof. Marie-Christine Simon from the University of Bonn is highly suitable for the Best Scholar Award, given her extensive experience and significant contributions to nutrition and microbiome research. Her profile stands out for the following reasons Prof. Simon has demonstrated in-depth knowledge in both nutrition and the human microbiome, focusing on the mechanistic roles of microbiota in human physiology and pathophysiology. Her research includes critical areas like immunology, metabolism, and diabetes-related changes, which are highly relevant in contemporary scientific discourse on public health and metabolic disorders.

Education:
  1. Ph.D. in Nutrition Science
    • Institution: German Diabetes Center, Düsseldorf, Germany.
    • Focus: Conducted human intervention studies; investigated the influence of probiotics on insulin resistance, the incretin effect, and inflammation in overweight and slim subjects. Gained extensive knowledge of diabetes-related metabolic and immune changes.
  2. Postdoctoral Research in Microbiome Research
    • Institution: Wallenberg Laboratory, University of Gothenburg, Sweden.
    • Supervisor: Prof. Fredrik Bäckhed.
    • Focus: Microbiome’s role in human physiology and pathophysiology, covering aspects of nutrition, immunology, and metabolism.

Work Experience:

  1. Junior Professor for Nutrition and Microbiome
    • Institution: Institute of Nutrition and Food Sciences, University of Bonn, Germany.
    • Role: Heads the junior research group for the Diet Body Brain competence cluster funded by the BMBF.
    • Research Focus: Extensive experience in nutrition-related microbiome research. Her team also investigates women’s health and the metabolic changes during the physiological cycle.
  2. Doctoral Research at German Diabetes Center
    • Institution: German Diabetes Center, Düsseldorf, Germany.
    • Role: Conducted significant research on probiotics and their effects on insulin resistance and inflammation.
  3. Postdoctoral Research
    • Institution: Wallenberg Laboratory, University of Gothenburg, Sweden.
    • Role: Developed a strong foundation in microbiome research, focusing on its role in human physiology.

Publication top Notes:

Effects of a biotechnologically produced Pleurotus sapidus mycelium on gut microbiome, liver transcriptome and plasma metabolome of broilers

Beneficial Effects of Synbiotics on the Gut Microbiome in Individuals with Low Fiber Intake: Secondary Analysis of a Double-Blind, Randomized Controlled Trial

Impact of Physiological Fluctuations of Sex Hormones During the Menstrual Cycle on Glucose Metabolism and the Gut Microbiota

Impact of the gut microbiome composition on social decision-making

Impact of Synbiotic Intake on Liver Metabolism in Metabolically Healthy Participants and Its Potential Preventive Effect on Metabolic-Dysfunction-Associated Fatty Liver Disease (MAFLD): A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial